Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2001-2010 of 2876 for cancer

Edit search filters
  1. CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study In Lung (DELFI-L201)

    Rochester, MN

  2. Patient Experience in Treatment for Low-grade Upper Tract Urothelial Carcinoma

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  3. Testing For Spread Of Stomach Cancer To Abdominal Cavity

    Rochester, MN

  4. School Employees Breast Cancer Risk Due To Environmental Exposures

    Rochester, MN

  5. A Study To Learn How Research Sites Successfully Recruited To A Geriatric Oncology Trial That Relied On Electronic Patient-reported Outcomes (EPRO)

    Rochester, MN

  6. Assessing Breast Cancer Risk Among Hispanic Women In Maricopa County

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. A Study To Evaluate DNA Evaluation Of Fragments For Early Interception - Lung Cancer Training Study

    Rochester, MN

  8. Using Induced-Pluripotent Stem Cells To Model Cancer Therapy-Related Adverse Events

    Jacksonville, FL

  9. A Study to Evaluate the Impact of a Pharmacist-led Oral Anticancer Medication (OAM) Program on Patient Outcomes

    La Crosse, WI

  10. Dynamics Of Clinical Trial Discussions In Oncology To Identify Patient Barriers And Help Develop A Patient-centered Intervention To Increase Participation In Clinical Trials

    Rochester, MN

.

Mayo Clinic Footer